Digipath Inc
OTC:DIGP
Relative Value
There is not enough data to reliably calculate the relative value of DIGP.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
DIGP Competitors Multiples
Digipath Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Digipath Inc
OTC:DIGP
|
3.4m USD | 0 | 3.7 | -2.9 | -2.9 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
98.6B USD | 0.3 | 213.3 | 14 | 14 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
65.9B EUR | 0.3 | 12.6 | 8 | 10.2 | |
| US |
|
Cigna Corp
NYSE:CI
|
78.6B USD | 0.3 | 12.7 | 0 | 0 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
28.5B EUR | 1.3 | 24.7 | 10.8 | 16.4 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.7B EUR | 1.2 | 32.9 | 10.4 | 22.1 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
24.1B USD | 1.7 | 27.6 | 14.7 | 20.6 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
23.4B USD | 2.2 | 24.8 | 13.3 | 17.9 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.7B EUR | 0.6 | 16.3 | 6.4 | 13.7 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
13.4B USD | 14.3 | -32.3 | -34.1 | -30.9 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10B USD | 0.8 | 13.7 | 7.2 | 9.8 |